{"component":{"type":17,"accent_color":3123338,"components":[{"type":10,"content":"-# WikiRNG · Roll of 10/18/2026 · by [mob](https://wikirng.com/u/mob)"},{"type":10,"content":"## [Desmoteplase](https://wikirng.com/roll/ceb9tfw9te)\n*Medication*"},{"type":10,"content":">>> Desmoteplase is a novel, highly fibrin-specific \"clot-busting\" (thrombolytic) drug in development that reached phase III clinical trials. The Danish pharmaceutical company, Lundbeck, owns the worldwide rights to Desmoteplase."},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"### 🟩 Notable · 52,253 SP\n-# Top 42%"},{"type":10,"content":"*The Danish is a highly fibrin-specific \"clot-busting\" (thrombolytic) drug pharmaceutical*"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"🟦 1️⃣ **In a Word** · Obscure · +26,337 SP\n-# Its short description is one word.\n🟩 🛰️ **Reuters** · Notable · +9,507 SP\n-# Links to Reuters.\n🟩 🧬 **PubMed** · Notable · +3,090 SP\n-# Links to PubMed.\n🟩 🔓 **Free to Read** · Notable · +1,731 SP\n-# Cites a source that is free to read.\n🟩 😏 **Nice ID** · Notable · +1,515 SP\n-# Page ID contains \"69\".\n🟩 🧹 **Dusty** · Notable · +1,209 SP\n-# Not edited in 2+ years.\n-# +20 more badges"},{"type":14,"divider":true,"spacing":1},{"type":1,"components":[{"type":2,"style":5,"label":"View roll","url":"https://wikirng.com/roll/ceb9tfw9te"},{"type":2,"style":5,"label":"Read on Wikipedia","url":"https://en.wikipedia.org/wiki/Desmoteplase"}]},{"type":10,"content":"-# Article text from Wikipedia, CC BY-SA 4.0"}]}}